{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T21:04:37Z","timestamp":1784754277615,"version":"3.55.0"},"reference-count":15,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Revue de M\u00e9decine Interne"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.revmed.2026.07.001","type":"journal-article","created":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T20:23:40Z","timestamp":1784751820000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["R\u00e9mission compl\u00e8te et prolong\u00e9e d\u2019une leuc\u00e9mie \u00e0 grands lymphocytes granuleux T r\u00e9fractaire trait\u00e9e par tofacitinib"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-9645-6573","authenticated-orcid":false,"given":"Ad\u00e8le","family":"Carr\u00e9","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8887-3233","authenticated-orcid":false,"given":"Samuel","family":"Deshayes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Martin-Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Comoz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-3760-9116","authenticated-orcid":false,"given":"Lassina","family":"Sere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hubert","family":"De Boysson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Achille","family":"Aouba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.revmed.2026.07.001_bib0080","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.3390\/cancers16071307","article-title":"Large granular lymphocytic leukemia: clinical features, molecular pathogenesis, diagnosis and treatment","volume":"16","author":"Ullah","year":"2024","journal-title":"Cancers"},{"key":"10.1016\/j.revmed.2026.07.001_bib0085","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0037-1963(03)00133-1","article-title":"Clinical features of large granular lymphocyte leukemia","volume":"40","author":"Lamy","year":"2003","journal-title":"Semin Hematol"},{"key":"10.1016\/j.revmed.2026.07.001_bib0090","doi-asserted-by":"crossref","first-page":"169","DOI":"10.7326\/0003-4819-102-2-169","article-title":"Leukemia of large granular lymphocytes: association with clonal chromosomal abnormalities and autoimmune neutropenia, thrombocytopenia, and hemolytic anemia","volume":"102","author":"Loughran","year":"1985","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.revmed.2026.07.001_bib0095","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1182\/blood-2007-06-093823","article-title":"Antigen activation and impaired Fas-induced death-inducing signaling complex formation in T-large-granular lymphocyte leukemia","volume":"111","author":"Yang","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.revmed.2026.07.001_bib0100","doi-asserted-by":"crossref","first-page":"4771","DOI":"10.1182\/blood.V92.12.4771","article-title":"Dysregulation of CD95\/CD95\u00a0ligand-apoptotic pathway in CD3(+) large granular lymphocyte leukemia","volume":"92","author":"Lamy","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.revmed.2026.07.001_bib0105","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1182\/blood-2017-09-808816","article-title":"TRAIL mediates and sustains constitutive NF-\u03baB activation in LGL leukemia","volume":"131","author":"Yang","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.revmed.2026.07.001_bib0110","doi-asserted-by":"crossref","first-page":"E368","DOI":"10.1002\/ajh.26275","article-title":"Ruxolitinib for refractory large granular lymphocyte leukemia","volume":"96","author":"Moignet","year":"2021","journal-title":"Am J Hematol"},{"key":"10.1016\/j.revmed.2026.07.001_bib0115","doi-asserted-by":"crossref","first-page":"97516","DOI":"10.18632\/oncotarget.22178","article-title":"Drug sensitivity profiling identifies potential therapies for lymphoproliferative disorders with overactive JAK\/STAT3\u00a0signaling","volume":"8","author":"Kuusanm\u00e4ki","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.revmed.2026.07.001_bib0120","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1038\/leu.2015.280","article-title":"Tofacitinib as a novel salvage therapy for refractory T-cell large granular lymphocytic leukemia","volume":"29","author":"Bilori","year":"2015","journal-title":"Leukemia"},{"key":"10.1016\/j.revmed.2026.07.001_bib0125","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1111\/bjh.19476","article-title":"Efficacy of ruxolitinib in the treatment of relapsed\/refractory large granular lymphocytic leukaemia","volume":"205","author":"Marchand","year":"2024","journal-title":"Br J Haematol"},{"key":"10.1016\/j.revmed.2026.07.001_bib0130","doi-asserted-by":"crossref","first-page":"2828","DOI":"10.1182\/blood.2021013379","article-title":"A phase 2\u00a0biomarker-driven study of ruxolitinib demonstrates effectiveness of JAK\/STAT targeting in T-cell lymphomas","volume":"138","author":"Moskowitz","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.revmed.2026.07.001_bib0135","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1111\/ced.14712","article-title":"Successful use of baricitinib in the treatment of refractory rheumatoid arthritis-associated Sweet syndrome","volume":"46","author":"Nousari","year":"2021","journal-title":"Clin Exp Dermatol"},{"issue":"6","key":"10.1016\/j.revmed.2026.07.001_bib0140","first-page":"15","article-title":"A case of filgrastim-induced neutrophilic dermatosis of the dorsal hands in a patient with Felty Syndrome","volume":"29","author":"Joshi","year":"2023","journal-title":"Dermatol Online J"},{"key":"10.1016\/j.revmed.2026.07.001_bib0145","doi-asserted-by":"crossref","first-page":"4435","DOI":"10.1182\/blood.V88.12.4435.bloodjournal88124435","article-title":"Multiple signaling pathways induced by granulocyte colony-stimulating factor involving activation of JAKs, STAT5, and\/or STAT3\u00a0are required for regulation of three distinct classes of immediate early genes","volume":"88","author":"Tian","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.revmed.2026.07.001_bib0075","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.1002\/art.10497","article-title":"Autoantibodies against granulocyte colony-stimulating factor in Felty's syndrome and neutropenic systemic lupus erythematosus","volume":"46","author":"Hellmich","year":"2002","journal-title":"Arthritis Rheum"}],"container-title":["La Revue de M\u00e9decine Interne"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866326006399?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866326006399?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T20:23:47Z","timestamp":1784751827000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0248866326006399"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":15,"alternative-id":["S0248866326006399"],"URL":"https:\/\/doi.org\/10.1016\/j.revmed.2026.07.001","relation":{},"ISSN":["0248-8663"],"issn-type":[{"value":"0248-8663","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"R\u00e9mission compl\u00e8te et prolong\u00e9e d\u2019une leuc\u00e9mie \u00e0 grands lymphocytes granuleux T r\u00e9fractaire trait\u00e9e par tofacitinib","name":"articletitle","label":"Article Title"},{"value":"La Revue de M\u00e9decine Interne","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.revmed.2026.07.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Soci\u00e9t\u00e9 Nationale Fran\u00e7aise de M\u00e9decine Interne (SNFMI). Published by Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}